Clinical Trials Directory

Trials / Conditions / Parkinsonian Disorders

Parkinsonian Disorders

33 registered clinical trials studyying Parkinsonian Disorders7 currently recruiting.

StatusTrialSponsorPhase
RecruitingSlowing Cognitive Decline in Alpha-synucleinopathies by Enhancing Physical Activity
NCT07324330
University Hospital, BonnN/A
Not Yet RecruitingSlow-SPEED: Slowing Parkinson's Early Through Exercise Dosage
NCT06993142
Radboud University Medical CenterN/A
Enrolling By InvitationAn Innovative Method in SAliva Samples for the Early Differential Diagnosis of High-impact NeuroDegenerative D
NCT06875739
Fondazione Don Carlo Gnocchi Onlus
RecruitingStudy of Axial and Cognitive Symptoms and Biomarkers of Neurodegeneration in Brain-first and Body-first PD
NCT07187843
Azienda USL Reggio Emilia - IRCCS
RecruitingSlow-SPEED-NL: Slowing Parkinson's Early Through Exercise Dosage-Netherlands
NCT06193252
Radboud University Medical CenterN/A
UnknownEffect of Motor Function, Depression and Sleep Quality on Attention in Parkinson's Disease
NCT06283043
Inonu University
UnknownMachine Vision Based MDS-UPDRS III Machine Rating
NCT05906719
Ruijin Hospital
CompletedExternal vs Internal-triggered Augmented-reality Visual Cues to Treat Freezing of Gait
NCT05608915
The Cleveland ClinicN/A
UnknownRole and Mechanism of Probiotics in Improving Motor Symptoms in Mild to Moderate Parkinson's Disease
NCT04871464
Beijing Friendship HospitalPhase 4
Active Not RecruitingLinac FRACtionated Radiosurgical THALamotomie in Tremors (FRACTHAL)
NCT04727658
Centre Hospitalier Universitaire de NicePhase 2
WithdrawnGentleCath Air (Urinary Self-catheterization) - Pain in Female Patients With Neurological Vesico-sphincter Dis
NCT04847609
ConvaTec Inc.
CompletedOral Health, Orofacial Function and Oral Health Care in Patients With Parkinson's Disease
NCT05356845
University of Copenhagen
CompletedComplex Eye Movements in Parkinson's Disease and Related Movement Disorders
NCT04925622
Saccadous, Inc.
UnknownIntensive Multidisciplinary Rehabilitation and Biomarkers in Parkinson's Disease
NCT05452655
Fondazione Don Carlo Gnocchi OnlusN/A
CompletedLatest Imaging SPECT System Evaluation Phase 1
NCT04704349
Centre Hospitalier Régional d'OrléansN/A
Active Not RecruitingThe Personalized Parkinson Project De Novo Cohort
NCT04985539
Radboud University Medical Center
CompletedMovement Disorders Analysis Using a Deep Learning Approach
NCT04974034
Hospital Avicenne
RecruitingThe National Registry Study For the Real-world Patients With Parkinsonian Disorders in China
NCT03649503
Huashan Hospital
CompletedtDCS Plus Physical Therapy for Progressive Supranuclear Palsy
NCT04237948
Fondazione Europea di Ricerca Biomedica Ferb OnlusN/A
CompletedSafety and Efficacy Study of VY-AADC01 for Advanced Parkinson's Disease
NCT03065192
Neurocrine BiosciencesPhase 1
Active Not RecruitingWest Sweden Parkinson Objective Measurement Registry Study
NCT03130595
Sahlgrenska University Hospital
CompletedAlpha-synuclein Level in Saliva to Differentiate Between Idiopathic Parkinson Disease and Iatrogenic Parkinson
NCT03156647
Centre Hospitalier Universitaire de Nīmes
RecruitingGait Analysis in Neurological Disease
NCT02994719
Beth Israel Deaconess Medical Center
Active Not RecruitingMobile Parkinson Observatory for Worldwide, Evidence-based Research (mPower)
NCT02696603
Sage BionetworksN/A
CompletedRepetitive Transcranial Magnetic Stimulation for Freezing of Gait
NCT01853150
Dongtan Sacred Heart HospitalN/A
CompletedPost-prandial Hypotension and Sleepiness in Parkinson's Disease and Other Synucleinopathies
NCT02021903
University Hospital, ToulouseN/A
CompletedEvaluation of the Efficacy and Safety of Modified Release AFQ056 in Parkinson's Patients With L-dopa Induced D
NCT01491529
Novartis PharmaceuticalsPhase 2
CompletedOpen-label, Long-term Safety Extension Study of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias
NCT01491932
Novartis PharmaceuticalsPhase 2
CompletedEvaluation of the Efficacy and Safety of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias
NCT01385592
Novartis PharmaceuticalsPhase 2
CompletedEffect of Undenatured Cysteine-Rich Whey Protein Isolate (HMS 90®) in Patients With Parkinson's Disease
NCT01662414
Chulalongkorn UniversityPhase 4
CompletedUsefulness of α-synuclein as a Marker for Early Diagnosis of Parkinson's Disease in Skin Biopsy.
NCT01380899
Universidad Autonoma de San Luis Potosí
UnknownSedation During Microelectrode Recordings Before Deep Brain Stimulation for Movement Disorders.
NCT00355927
Hadassah Medical OrganizationN/A
TerminatedStudy of Preladenant for the Treatment of Antipsychotic Induced Movement Disorders in Participants With Schizo
NCT00686699
Merck Sharp & Dohme LLCPhase 2